Aerovate Therapeutics Inc

NASDAQ:AVTE   3:59:53 PM EDT
21.16
-0.40 (-1.86%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aerovate Therapeutics Inc Stock, NASDAQ:AVTE

200 Berkeley Street, 18th floor, Boston, Massachusetts 02116
United States of America
Phone: +1.617.443.2400
Number of Employees:

Description

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focus on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake in July 27, 2018 and is headquartered in Boston, MA.